These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19074777)

  • 41. Forty-year trends in menopausal hormone therapy use and breast cancer incidence among postmenopausal black and white women.
    Chlebowski RT; Aragaki AK; Anderson GL; Prentice RL
    Cancer; 2020 Jul; 126(13):2956-2964. PubMed ID: 32212335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
    Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L
    BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral contraceptive formulation and risk of breast cancer.
    Marchbanks PA; Curtis KM; Mandel MG; Wilson HG; Jeng G; Folger SG; McDonald JA; Daling JR; Bernstein L; Malone KE; Wingo PA; Simon MS; Norman SA; Strom BL; Ursin G; Weiss LK; Burkman RT; Spirtas R
    Contraception; 2012 Apr; 85(4):342-50. PubMed ID: 22067757
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral contraceptives and breast cancer.
    Brinton LA; Hoover R; Szklo M; Fraumeni JF
    Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study Group.
    Figueiredo JC; Bernstein L; Capanu M; Malone KE; Lynch CF; Anton-Culver H; Stovall M; Bertelsen L; Haile RW; Bernstein JL;
    J Clin Oncol; 2008 Mar; 26(9):1411-8. PubMed ID: 18250348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives.
    Shapiro S; Rosenberg L; Hoffman M; Truter H; Cooper D; Rao S; Dent D; Gudgeon A; van Zyl J; Katzenellenbogen J; Baillie R
    Am J Epidemiol; 2000 Feb; 151(4):396-403. PubMed ID: 10695598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Breast cancer before age 45 and oral contraceptive use: new findings.
    Miller DR; Rosenberg L; Kaufman DW; Stolley P; Warshauer ME; Shapiro S
    Am J Epidemiol; 1989 Feb; 129(2):269-80. PubMed ID: 2912040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A case-control study of the risk of breast cancer in relation to oral contraceptive use.
    Rosenberg L; Palmer JR; Clarke EA; Shapiro S
    Am J Epidemiol; 1992 Dec; 136(12):1437-44. PubMed ID: 1288273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women.
    Trabert B; Malone KE; Daling JR; Doody DR; Bernstein L; Ursin G; Marchbanks PA; Strom BL; Humphrey MC; Ostrander EA
    Breast Cancer Res; 2007; 9(6):R84. PubMed ID: 18067661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral contraceptive use and risk of breast carcinoma in situ (United States).
    Gill JK; Press MF; Patel AV; Bernstein L
    Cancer Causes Control; 2006 Nov; 17(9):1155-62. PubMed ID: 17006721
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study.
    Urban M; Banks E; Egger S; Canfell K; O'Connell D; Beral V; Sitas F
    PLoS Med; 2012; 9(3):e1001182. PubMed ID: 22412354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent trends in breast cancer among younger women in the United States.
    Brinton LA; Sherman ME; Carreon JD; Anderson WF
    J Natl Cancer Inst; 2008 Nov; 100(22):1643-8. PubMed ID: 19001605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral contraceptives and breast cancer: review of the epidemiologic literature.
    Thomas DB
    Contraception; 1991 Jun; 43(6):597-642. PubMed ID: 1868735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral contraceptives and breast cancer.
    Jick H; Walker AM; Watkins RN; D'Ewart DC; Hunter JR; Danford A; Madsen S; Dinan BJ; Rothman KJ
    Am J Epidemiol; 1980 Nov; 112(5):577-85. PubMed ID: 7435486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The pill and cancer: a review of the literature. A case of swings and roundabouts?
    Knowlden HA
    J Adv Nurs; 1990 Sep; 15(9):1016-20. PubMed ID: 2229699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral contraceptive use and risk of breast carcinoma in situ.
    Nichols HB; Trentham-Dietz A; Egan KM; Titus-Ernstoff L; Hampton JM; Newcomb PA
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2262-8. PubMed ID: 18006914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Latest views on pill prescribing.
    Kay CR
    J R Coll Gen Pract; 1984 Nov; 34(268):611-4. PubMed ID: 6502571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Breast cancer risk and oral contraceptive use: results from a large case-control study.
    Weinstein AL; Mahoney MC; Nasca PC; Leske MC; Varma AO
    Epidemiology; 1991 Sep; 2(5):353-8. PubMed ID: 1742384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.